TickerFacts.

Novavax Inc (NVAX): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2016-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2021-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

$265.46M
Year ended 2021-12-31
2009-12-31: -$33.58M2010-12-31: -$34.41M2011-12-31: -$24.24M2012-12-31: -$22.57M2015-12-31: -$144.36M2016-12-31: -$276.97M2017-12-31: -$148.66M2018-12-31: -$186.20M2019-12-31: -$138.48M2020-12-31: -$97.16M2021-12-31: $265.46M$265.46M
2009-12-31 Free Cash Flow (USD) 2021-12-31
Period endedFree Cash FlowChange YoYSource filing
2021-12-31$265.46Mn/m2024-02-28, From 2021-01-01
2020-12-31-$97.16Mn/m2023-02-28, From 2020-01-01
2019-12-31-$138.48Mn/m2022-03-01, From 2019-01-01
2018-12-31-$186.20Mn/m2021-03-01, From 2018-01-01
2017-12-31-$148.66Mn/m2020-03-11, From 2017-01-01
2016-12-31-$276.97Mn/c2019-03-18, From 2016-01-01
2015-12-31-$144.36Mn/a2018-03-14, From 2015-01-01
No annual figure between 2012-12-31 and 2015-12-31.
2012-12-31-$22.57Mn/m2015-02-27, From 2012-01-01
2011-12-31-$24.24Mn/m2014-03-12, From 2011-01-01
2010-12-31-$34.41Mn/m2013-03-12, From 2010-01-01
2009-12-31-$33.58Mn/a2012-03-14, From 2009-01-01